T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine

Mucosal Immunology

Volumn 5, Issue 3, 2012, Pages 311-319

  Weaver, E A ^a   Mercier, G T ^b   Gottschalk, S ^c   Barry, M A ^a,d  

^a MAYO CLINIC   (United States)

^b University of Houston   (United States)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VACCINE; ADENOVIRUS VECTOR; GAG PROTEIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SIGMA1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

EID: 84859835483     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.11     Document Type: Article

References (17)

1. Lehner , T. & Anton , P. A. Mucosal immunity and vaccination against HIV. AIDS 16 (Suppl 4) , S125-S132 ( 2002 ).
2. Simecka , J. W. Mucosal immunity of the gastrointestinal tract and oral tolerance. Adv. Drug Deliv. Rev. 34 , 235-259 ( 1998 ).
3. Kaneko , H. et al. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology 267 , 8-16 ( 2000 ).
4. Bergelson , J. M. et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (New York, NY) 275 , 1320-1323 ( 1997 ).
5. Wickham , T. J. , Mathias , P. , Cheresh , D. A. & Nemerow , G. R. Integrins avb3 or avb5 promote adenovirus internalization but not virus attachment. Cell 73 , 309-319 ( 1993 ).
6. Zabner , J. , Freimuth , P. , Puga , A. , Fabrega , A. & Welsh , M. J. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J. Clin. Invest. 100 , 1144-1149 ( 1997 ).
7. Grubb , B. R. et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371 , 802-806 ( 1994 ).
8. Mercier , G. T. , Campbell , J. A. , Chappell , J. D. , Stehle , T. , Dermody , T. S. & Barry , M. A. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proc. Natl. Acad. Sci. USA 101 , 6188-6193 ( 2004 ).
9. Chappell , J. D. , Gunn , V. L. , Wetzel , J. D. , Baer , G. S. & Dermody , T. S. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J. Virol. 71 , 1834-1841 ( 1997 ).
10. Forrest , J. C. , Campbell , J. A. , Schelling , P. , Stehle , T. & Dermody , T. S. Structure-function analysis of reovirus binding to junctional adhesion molecule 1: Implications for the mechanism of reovirus attachment. J. Biol. Chem. 278 , 48434-48444 ( 2003 ).
11. Von Seggern , D. J. , Huang , S. , Fleck , S. K. , Stevenson , S. C. & Nemerow , G. R. Adenovirus vector pseudotyping in fiber-expressing cell lines: Improved transduction of Epstein-Barr virus-transformed B cells. J. Virol. 74 , 354-362 ( 2000 ).
12. Campos , S. K. & Barry , M. A. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombination. Hum. Gene Ther. 15 , 1125-1130 ( 2004 ).
13. Mok , H. , Palmer , D. J. , Ng , P. & Barry , M. A. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol. Ther. 11 , 66-79 ( 2005 ).
14. Hofherr , S. E. , Shashkova , E. V. , Weaver , E. A. , Khare , R. & Barry , M. A. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol. Ther. 16 , 1276-1282 ( 2008 ).
15. Mercier , G. T. et al. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine 25 , 8687-8701 ( 2007 ).
16. Gottschalk , S. et al. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood 101 , 1905-1912 ( 2003 ).
17. Leen , A. M. et al. Fiber-modified adenoviruses generate subgroup crossreactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103 , 1011-1019 ( 2004 ).